Literature DB >> 24619867

A 'waterfall' transfer-based workflow for improved quality of tissue microarray construction and processing in breast cancer research.

M Oberländer1, H Alkemade, S Bünger, F Ernst, C Thorns, T Braunschweig, J K Habermann.   

Abstract

A major focus in cancer research is the identification of biomarkers for early diagnosis, therapy prediction and prognosis. Hereby, validation of target proteins on clinical samples is of high importance. Tissue microarrays (TMAs) represent an essential advancement for high-throughput analysis by assembling large numbers of tissue cores with high efficacy and comparability. However, limitations along TMA construction and processing exist. In our presented study, we had to overcome several obstacles in the construction and processing of high-density breast cancer TMAs to ensure good quality sections for further research. Exemplarily, 406 breast tissue cores from formalin-fixed and paraffin embedded samples of 245 patients were placed onto three recipient paraffin blocks. Sectioning was performed using a rotary microtome with a "waterfall" automated transfer system. Sections were stained by immunohistochemistry and immunofluorescence for nine proteins. The number and quality of cores after sectioning and staining was counted manually for each marker. In total, 97.1 % of all cores were available after sectioning, while further 96 % of the remaining cores were evaluable after staining. Thereby, normal tissue cores were more often lost compared to tumor tissue cores. Our workflow provides a robust method for manufacturing high-density breast cancer TMAs for subsequent IHC or IF staining without significant sample loss.

Entities:  

Mesh:

Year:  2014        PMID: 24619867     DOI: 10.1007/s12253-014-9752-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  32 in total

1.  Tape transfer sectioning of tissue microarrays introduces nonspecific immunohistochemical staining artifacts.

Authors:  D Catchpoole; N Mackie; S McIver; A Chetcuti; A Henwood; N Graf; S Arbuckle
Journal:  Biotech Histochem       Date:  2010-11-22       Impact factor: 1.718

Review 2.  Tissue microarrays: bridging the gap between research and the clinic.

Authors:  Till Braunschweig; Joon-Yong Chung; Stephen M Hewitt
Journal:  Expert Rev Proteomics       Date:  2005-06       Impact factor: 3.940

Review 3.  A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.

Authors:  Robert L Camp; Veronique Neumeister; David L Rimm
Journal:  J Clin Oncol       Date:  2008-10-20       Impact factor: 44.544

4.  Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues.

Authors:  David L Rimm; Torsten O Nielsen; Scott D Jewell; Daniel C Rohrer; Gloria Broadwater; Frederic Waldman; Kisha A Mitchell; Baljit Singh; Gregory J Tsongalis; Wendy L Frankel; Anthony M Magliocco; Jonathan F Lara; Eric D Hsi; Ira J Bleiweiss; Sunil S Badve; Beiyun Chen; Peter M Ravdin; Richard L Schilsky; Ann Thor; Donald A Berry
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

5.  A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously.

Authors:  W H Wan; M B Fortuna; P Furmanski
Journal:  J Immunol Methods       Date:  1987-10-23       Impact factor: 2.303

6.  Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.

Authors:  Katrine L Henriksen; Birgitte B Rasmussen; Anne E Lykkesfeldt; Susann Møller; Bent Ejlertsen; Henning T Mouridsen
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

Review 7.  Targeted therapies: how personal should we go?

Authors:  Miriam Martini; Loredana Vecchione; Salvatore Siena; Sabine Tejpar; Alberto Bardelli
Journal:  Nat Rev Clin Oncol       Date:  2011-11-15       Impact factor: 66.675

8.  Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.

Authors:  Kyle A Divito; Aaron J Berger; Robert L Camp; Marisa Dolled-Filhart; David L Rimm; Harriet M Kluger
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

9.  Loss of antigenicity in stored sections of breast cancer tissue microarrays.

Authors:  Jennifer H Fergenbaum; Montserrat Garcia-Closas; Stephen M Hewitt; Jolanta Lissowska; Lori C Sakoda; Mark E Sherman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-04       Impact factor: 4.254

10.  An inexpensive method of small paraffin tissue microarrays using mechanical pencil tips.

Authors:  Abdelhadi M Shebl; Khaled R Zalata; Maha M Amin; Amira K El-Hawary
Journal:  Diagn Pathol       Date:  2011-12-01       Impact factor: 2.644

View more
  6 in total

1.  Claudin-1 expression in cervical cancer.

Authors:  Friederike Hoellen; Annika Waldmann; Constanze Banz-Jansen; Uwe Holtrich; Thomas Karn; Martina Oberländer; Jens K Habermann; Mareike Hörmann; Frank Köster; Julika Ribbat-Idel; Marc Thill; Achim Rody; Ahmed El-Balat; Lars Hanker
Journal:  Mol Clin Oncol       Date:  2017-08-25

2.  HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.

Authors:  Tolga Acun; Natalie Doberstein; Jens K Habermann; Timo Gemoll; Christoph Thorns; Emin Oztas; Thomas Ried
Journal:  OMICS       Date:  2017-05

3.  The impact of CBP expression in estrogen receptor-positive breast cancer.

Authors:  Wafaa S Ramadan; Iman M Talaat; Mahmood Y Hachim; Annette Lischka; Timo Gemoll; Raafat El-Awady
Journal:  Clin Epigenetics       Date:  2021-04-07       Impact factor: 6.551

4.  SATB1, genomic instability and Gleason grading constitute a novel risk score for prostate cancer.

Authors:  Christoph Dumke; Timo Gemoll; Martina Oberländer; Sandra Freitag-Wolf; Christoph Thorns; Axel Glaessgen; Rinse Klooster; Silvère M van der Maarel; Jerker Widengren; Christian Doehn; Gert Auer; Jens K Habermann
Journal:  Sci Rep       Date:  2021-12-27       Impact factor: 4.379

5.  Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion.

Authors:  Friederike Hoellen; Annika Waldmann; Constanze Banz-Jansen; Achim Rody; Maria Heide; Frank Köster; Julika Ribbat-Idel; Christoph Thorns; Maximilian Gebhard; Martina Oberländer; Jens K Habermann; Marc Thill
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

6.  BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays.

Authors:  Abeer M Mahmoud; Virgilia Macias; Umaima Al-Alem; Ryan J Deaton; Andre Kadjaksy-Balla; Peter H Gann; Garth H Rauscher
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.